NEW YORK (Reuters) - Momenta Pharmaceuticals Inc said on Friday U.S. regulators had accepted for review its generic version of Teva Pharmaceutical Industries Ltd's multiple sclerosis drug Copaxone, ...

TEL AVIV, July 14 (Reuters) - There will not be any generic version of Teva Pharmaceutical Industries' multiple sclerosis drug Copaxone before 2014, the company's president and chief executive said in ...

Sandoz, a global leader in generic pharmaceuticals and a subsidiary of Novartis, has received approval from the US Food and Drug Administration (FDA) for Glatopa, the first generic version of Teva's ...